Long‐term treatment with fostamatinib in Japanese patients with primary immune thrombocytopenia: An open‐label extension study following a phase 3 placebo‐controlled, double‐blind, parallel‐group study

Documenti analoghi

• Treatment with fostamatinib in patients with immune thrombocytopenia: Experience from the Andalusian region in Spain—The Fostasur Study
  di: Reyes Jiménez‐Bárcenas, et al.
  Pubblicazione: (2024)
• Generalized modular equations and the CM values of Hauptmoduln
  di: Tomiyama, Kazuki
  Pubblicazione: (2025)
• Inhibition of FcRn with rozanolixizumab in adults with immune thrombocytopenia: Two randomised, double‐blind, placebo‐controlled phase 3 studies and their open‐label extension
  di: Nichola Cooper, et al.
  Pubblicazione: (2024)
• On collection schemes and Gaifman's splitting theorem
  di: Kurahashi, Taishi, et al.
  Pubblicazione: (2024)
• Screening of Adsorbable Per‐ and Polyfluoroalkyl Substances in Aqueous Environments Using Pyrolysis–GC–MS
  di: Hiroyuki Yanagisawa, et al.
  Pubblicazione: (2026)